ROMO1 and glioblastoma: We analyzed the survival information of the patients with the mRNA microarray data (n=511) from the Glioblastoma Multiforme dataset of TCGA database, and found that the overall survival of the patients with high expression of Romo1 (n=127, top 25% in rank) was significantly lower than the patients with low expression of Romo1 (n=384, bottom 75% in rank, p<0.0001, Figure 1B), indicating that the high expression of Romo1 may participate in the progression of glioblastoma.